NeuroNova
NeuroNova is develops drug targets and candidates that demonstrate potential in the treatment of neurodegenerative diseases.
NeuroNova is active in the biotechnology, medical, pharmaceutical space based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 1998.
Within the biotechnology, medical, pharmaceutical space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
The company is listed at the Private company stage of development.
| Sector | Biotechnology, Medical, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 1998 |
| Stage | Private company |
Website: www.neuronova.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account